top of page
Publicatoin.png

Selected Publications

2024

2023

  • Cronin SJF, Andrews NA, Latremoliere A. Peripheralized sepiapterin reductase inhibition as a safe analgesic therapy. Front Pharmacol. 2023 May 12;14:1173599. doi: 10.3389/fphar.2023.1173599. PMID: 37251335; PMCID: PMC10213231.

  • Sprague JM, Yekkirala AS, Singh B, Tochitsky I, Stephens M, Viramontes O, Ivanis J, Biscola NP, Havton LA, Woolf CJ, Latremoliere A. Bortezomib-induced neuropathy is in part mediated by the sensitization of TRPV1 channels. Commun Biol. 2023 Dec 5;6(1):1228. doi: 10.1038/s42003-023-05624-1. PMID: 38052846; PMCID: PMC10698173.

  • Singer ML, Shin MK, Kim LJ, Freire C, Aung O, Pho H, East JA, Sgambati FP, Latremoliere A, Pham LV, Polotsky VY. The efficacy of intranasal leptin for opioid-induced respiratory depression depends on sex and obesity state. Front Physiol. 2023 Dec 13;14:1320151. doi: 10.3389/fphys.2023.1320151. PMID: 38162827; PMCID: PMC10756673.

2022

2021

2020

2019

2018

2017

2016

2015

2014

2012

2011

2010

2009

2008

2007

2005

Contact
Information

The Sleep and Pain Research lab

Johns Hopkins Neurosurgery Pain Research Institute 

Department of Neurosurgery

855 North Wolfe St. Suite 625
Baltimore, MD 21205

443-287-8810

Thanks for submitting!

©2023 by The Latremoliere Lab

bottom of page